Tango Therapeutics, Inc. (TNGX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $112.28M | +61.5% |
| 2024 | $69.53M | +4.7% |
| 2023 | $66.39M | +10.7% |
| 2022 | $59.97M | -58.0% |
| 2021 | $142.75M | +403.0% |
| 2020 | $28.38M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $112.28M | +61.5% |
| 2024 | $69.53M | +4.7% |
| 2023 | $66.39M | +10.7% |
| 2022 | $59.97M | -58.0% |
| 2021 | $142.75M | +403.0% |
| 2020 | $28.38M | — |